patients’ perspectives on cdk4/6 inhibitors
Published 5 years ago • 51 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
2:58
patients’ perspectives on cdk4/6 inhibitors
-
3:12
educating patients and staff on using cdk4/6 inhibitors
-
8:11
best practices for managing patients on cdk4/6 inhibitors
-
5:34
considerations for treating patients with cdk4/6 inhibitors
-
30:52
esmo 2017: cdk4/6 inhibitors from a patient’s perspective
-
10:47
patient management of cdk 4/6 inhibitors
-
3:27
metastatic breast cancer: cdk4/6 inhibitors
-
6:18
adherence with cdk4/6 inhibitors
-
5:38
cdk4/6 inhibitors in metastatic breast cancer
-
9:02
cdk 4/6 inhibitors and identifying ild in patients
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
2:27
dr. o’shaughnessy on differentiating between cdk 4/6 inhibitors
-
5:34
considerations for treating patients with cdk4/6 inhibitors
-
1:51
reflecting on the use of cdk4/6 inhibitors in hr breast cancer
-
8:55
cdk4/6 inhibitors in hr metastatic breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
2:27
understanding abemaciclib: a new cdk4/6 inhibitor
-
3:38
mbc: cdk4/6 inhibitor patient selection/sequencing
-
1:47
dr. tripathy on combination strategies with cdk4/6 inhibitors in breast cancer